Premium
The acceptability of resin therapy to patients attending a hospital lipid clinic.
Author(s) -
Iversen SA,
Davidson D,
Davidson C
Publication year - 1995
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1995.tb04542.x
Subject(s) - medicine , crossover study , cholestyramine , palatability , orange (colour) , cholesterol , placebo , food science , chemistry , alternative medicine , pathology
Low dose cholestyramine ('Questran A') and colestipol ('Colestid Orange') were compared in a blinded two period crossover study of 55 patients attending a hospital lipid clinic. Colestipol was rated higher on a combined acceptability/palatability score. Both treatments reduced low density lipoprotein (LDL) cholesterol to a similar extent.